相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Iron metabolism and iron disorders revisited in the hepcidin era
Clara Camaschella et al.
HAEMATOLOGICA (2020)
The ectodomain of matriptase-2 plays an important nonproteolytic role in suppressing hepcidin expression in mice
Caroline A. Enns et al.
BLOOD (2020)
SLN124, a GalNAc-siRNA Conjugate Targeting TMPRSS6, Efficiently Prevents Iron Overload in Hereditary Haemochromatosis Type 1
Sandro Altamura et al.
HEMASPHERE (2019)
Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis
Zachary J. Hawula et al.
PHARMACEUTICALS (2019)
Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human Hepatocytes
Francois Beliveau et al.
CELL CHEMICAL BIOLOGY (2019)
RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia
Paul J. Schmidt et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Combination of Tmprss6-ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia
Carla Casu et al.
HAEMATOLOGICA (2016)
Combination of Tmprss6-ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia
Carla Casu et al.
HAEMATOLOGICA (2016)
Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia
Paul J. Schmidt et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe-/- mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia
Paul J. Schmidt et al.
BLOOD (2013)
Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice
Shuling Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
分享论文
